These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2006-001973-10 A Phase 2 Study comparing sequential satraplatin and erlotinib to single-agent erlotinib in patients >70 years of age with unresectable stage 3 or 4 Non-small Cell Lung Cancer as 1st-line therapy 2009-03-26 due-trials